Skip to Main Content

Paper Details

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.
Commun Med (Lond)
4
2022
Author NameAffiliation
Christopher P EvansUniversity of California Davis
Christopher P EvansUC Davis Comprehensive Cancer Center, University of California Davis
Eva CoreyUniversity of Washington
  • 1 - 3

Datasets

Release 1.2